News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
830,320 Results
Type
Article (85536)
Company Profile (702)
Press Release (744082)
Section
Business (231921)
Career Advice (4112)
Deals (39653)
Drug Delivery (120)
Drug Development (90603)
Employer Resources (194)
FDA (17916)
Job Trends (17272)
News (395002)
Policy (39594)
Tag
Academia (2972)
Alliances (56461)
Alzheimer's disease (1349)
Approvals (17877)
Artificial intelligence (135)
Bankruptcy (394)
Best Places to Work (12466)
Biotechnology (485)
Breast cancer (154)
Cancer (1243)
Career advice (3517)
CAR-T (102)
Cell therapy (302)
Clinical research (71662)
Collaboration (453)
Compensation (218)
COVID-19 (2790)
C-suite (101)
Data (1187)
Diabetes (130)
Diagnostics (6609)
Earnings (94119)
Employer resources (166)
Events (126570)
Executive appointments (337)
FDA (18446)
Funding (376)
Gene therapy (205)
GLP-1 (651)
Government (5026)
Healthcare (20650)
Infectious disease (2866)
Inflammatory bowel disease (125)
Interviews (808)
IPO (17570)
Job creations (5179)
Job search strategy (2856)
Layoffs (488)
Legal (10020)
Lung cancer (182)
Manufacturing (202)
Medical device (14255)
Medtech (14260)
Mergers & acquisitions (22073)
Metabolic disorders (420)
Neuroscience (1651)
NextGen Class of 2024 (7648)
Non-profit (5051)
Northern California (1504)
Obesity (233)
Opinion (249)
Patents (106)
People (64173)
Pharmaceutical (141)
Phase I (22105)
Phase II (31144)
Phase III (23447)
Pipeline (457)
Podcasts (96)
Postmarket research (3540)
Preclinical (9973)
Radiopharmaceuticals (243)
Rare diseases (247)
Real estate (7368)
Regulatory (25927)
Research institute (2638)
Resumes & cover letters (649)
Southern California (1302)
Startups (4272)
United States (13711)
Vaccines (625)
Weight loss (187)
Date
Today (96)
Last 7 days (505)
Last 30 days (1940)
Last 365 days (34157)
2024 (33989)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57670)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1261)
Arizona (216)
Asia (49338)
Australia (8706)
California (3434)
Canada (1191)
China (286)
Colorado (107)
Connecticut (144)
Europe (112890)
Florida (396)
Illinois (359)
Indiana (203)
Kansas (104)
Maryland (623)
Massachusetts (2822)
Michigan (154)
Minnesota (255)
New Jersey (1004)
New York (960)
North Carolina (813)
Northern California (1504)
Ohio (122)
Pennsylvania (782)
South America (1646)
Southern California (1302)
Texas (448)
Washington State (387)
830,320 Results for "glympse bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Sunbird Bio Merges with Glympse Bio to Accelerate Development of Proprietary Protein-Based Diagnostic Technologies
Sunbird Bio, a biotechnology company developing proprietary protein-based technologies to improve diagnosis and treatment of neurological disorders and early-stage cancer, announced that they have completed a merger with Glympse Bio to accelerate development of the companies’ protein-based diagnostic platforms.
August 9, 2023
·
5 min read
Layoffs
Bluebird Bio to Lay Off 25% of Workforce
About a month after reporting it’s had a tough time starting enough patients on its treatments, bluebird bio announced it will lay off about 25% of its employees, over half of whom work in R&D.
September 24, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Mercury Bio Appoints Biotech Innovator Alex Koglin, Ph.D. to Board of Directors
With the addition of NTx’s co-founder and former President to the board Mercury Bio significantly enhances its strategic reach in the biotech sector
October 1, 2024
·
2 min read
Layoffs
IN8bio to Lay Off About 49% of Employees
Facing financial challenges, IN8bio is looking to preserve cash resources through a pipeline prioritization and layoffs at its New York City and Birmingham, Alabama, sites.
September 5, 2024
·
1 min read
·
Angela Gabriel
BioMidwest
Aruna Bio to Present at BIO International Convention 2024
Aruna Bio, Inc. announced that Stephen From, Chief Executive Officer of Aruna Bio, will be presenting a corporate overview at the 2024 BIO International Convention being held June 3-6, 2024 at the San Diego Convention Center, California.
May 28, 2024
·
1 min read
Press Releases
Climb Bio to be Added to the Nasdaq Biotechnology Index
December 19, 2024
·
4 min read
Lone Star Bio
Matica Bio at BIO International 2024: Leading the Way in CGT Innovation and U.S. Manufacturing Strategy
Matica Biotechnology (Matica Bio) announced today that it will participate in the world’s largest biotech exhibition, the BIO International Convention (BIO USA).
May 22, 2024
·
4 min read
Pharm Country
BlueSphere Bio to Present Corporate Update and Participate in a Panel Discussion at the 2024 BIO International Convention
BlueSphere Bio today announced that Keir Loiacono, Esq., Chief Executive Officer of BlueSphere Bio, will provide a corporate update and participate in a panel discussion at the 2024 BIO International convention being held from June 3 – 6, 2024.
May 30, 2024
·
3 min read
Press Releases
New Combination Data of Secura Bio’s COPIKTRA® (duvelisib) Presented at the 2024 American Society of Hematology Meeting
December 10, 2024
·
7 min read
Collaboration
Novartis, Dren Bio Ink Potential $3B Deal for Anti-Myeloid Bispecific Antibodies for Cancer
Novartis continues its dealmaking spree with a bet on Dren Bio’s Targeted Myeloid Engager and Phagocytosis platform to develop bispecific antibodies in oncology.
July 25, 2024
·
2 min read
·
Tristan Manalac
1 of 83,032
Next
